drugset / Trial / NCT04372420
Bone Morphogenetic Protein-2 In Grade II Furcation Defects.
RandomizedParallel-groupDouble-blindTreatment
Summary
The present study evaluated clinically and radiographically the regenerative potential of rhBMP-2 in absorbable sponge and PRF in Grade II furcation.
Timeline
- Start
- 2017-12-05
- Primary completion
- 2019-09-19
- Completion
- 2019-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rhBMP-2 | Protein / enzyme biologic | 0.5 ug/ml | Other |